Partners Hazel Ford and Alexander Robinson have been featured in the Life Sciences IP Review (LSIPR) providing insights on the latest developments impacting the European Patent Office Boards of Appeal, following their discussion held at LSPN Spring North America 2025.
In their talk, they analyse the evolving legal landscape in the life sciences sector in light of recent decisions prompted by the Unified Patent Court, offering a valuable perspective on how these changes may affect patent strategies across Europe.
To watch the full video click here.
